Malaysia’s DCA has given conditional approval for Takeda’s Qdenga dengue vaccine for use in people aged ≥4 years, after evaluation of the vaccine’s safety, efficacy, and quality. WHO has recommended use of Qdenga in places with high dengue disease burden.